Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause Osteoporosis? 86 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Osteoporosis have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.4% of all adverse event reports for SITAGLIPTIN.

86
Reports of Osteoporosis with SITAGLIPTIN
0.4%
of all SITAGLIPTIN reports
22
Deaths
30
Hospitalizations

How Dangerous Is Osteoporosis From SITAGLIPTIN?

Of the 86 reports, 22 (25.6%) resulted in death, 30 (34.9%) required hospitalization, and 10 (11.6%) were considered life-threatening.

Is Osteoporosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 86 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause Osteoporosis?

EMTRICITABINE\TENOFOVIR DISOPROXIL (7,436) TENOFOVIR DISOPROXIL (5,302) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,029) ADALIMUMAB (2,665) PREDNISONE (2,476) METHOTREXATE (2,018) ETANERCEPT (1,766) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,720) TOCILIZUMAB (1,689) ALENDRONATE (1,688)

Which SITAGLIPTIN Alternatives Have Lower Osteoporosis Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All Osteoporosis Reports All Drugs Causing Osteoporosis SITAGLIPTIN Demographics